VBI Vaccines financials at a glance

+ Portfolio

The revenue of VBI Vaccines is reported as 0.00868 billion Dollars in the fiscal year 2023. The earnings were 0 Dollars per share in 2023, which was 54.35 higher than 2019. And about -0.04834 billion Dollars are reported as free cash flow in the financials of VBI Vaccines 2023. No dividends were paid to the shareholders of the VBI Vaccines stock NasdaqCM:VBIV in the financial year 2023.

Forecast

Financials

Year	Year	TTM	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	$1.06M	$2.22M	$3.36M	$0.87M	$0.55M	$0.00M
GM %	Gross Margin %	-58.73%	0.00%	-,255.88%	-34.40%	0.00%	0.00%	-,292.98%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-9.75	$-6.30	$-13.80	$-29.10	$-26.40	$-23.10	$-36.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0
Sha.	Shares	N/AM	8.47M	5.94M	3.26M	2.14M	1.33M	0.63M
OCF	Operating Cash Flow	N/A	$-47.05M	$-48.71M	$-45.53M	$-31.38M	$-18.52M	$0.00M
FCF	Free Cash Flow	N/A	$-48.05M	$-52.38M	$-51.52M	$-32.02M	$-19.11M	$0.00M
FCFS	Free Cash Flow Per Share	$-5.94	$-0.22	$-0.44	$-0.78	$-0.73	$-0.64	$-0.77

VBI Vaccines financials at a glance

Financials

Discover